Characterizing Complication Risk from Multisite, Intermittent Transfusions for the Treatment of Sickle Cell Disease

Characterizing Complication Risk from Multisite, Intermittent Transfusions for the Treatment of Sickle Cell Disease

Blood transfusions are indicated for some acute complications of sickle cell disease. To characterize the SCD population at increased risk of transfusion-associated complications, Georgia hospital discharge data were used to estimate the frequency of intermittent transfusions and the proportion of patients receiving them at multiple institutions.

Tang, A., Branscomb, J., Zhou, M., Snyder, A., Eckman, J. (2019). Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell disease. Pediatric Blood & Cancer, 23(10). DOI: 10.1002/pbc.27921.